|
|
||||||||
1Department of Biochemistry and Molecular Biology and 2Department of Obstetrics and Gynecology, University Hospital of Puerto Real; 3Department of Cell Biology and Histology, School of Medicine, University of Cádiz, Cadiz, Spain; and 4School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina
Submitted 16 May 2005 ; accepted in final form 3 July 2005
Female rats were treated with FSH (40 IU/kg) on the first and second diestrus days (D1 and D2) and with LH (40 IU/kg) on the proestrus (P) day to synchronize and maximize ovarian changes. Follicle area increased by 50% from D1 to P, and the estrus (E) phase showed multiple corpora lutea and massive apoptosis. Increased oxygen uptakes (42102%) were determined in ovary slices and in isolated mitochondria in active state 3 along the proliferation phase (D1-D2-P) that returned to initial values in the E phase. Mitochondrial content and the electron transfer activities of complexes I and IV were also maximal in the P phase (2079% higher than in D1). Production of NO by mitochondrial nitric oxide synthase (mtNOS), biochemically determined, and the mtNOS functional activity in regulating state 3 oxygen uptake were also maximal at P and 7988% higher than at D1. The moderately increased rate of NO in the proliferative phase is associated with mitochondrial biogenesis, whereas the high rate of NO generation by mtNOS at phase P appears to trigger mitochondria-dependent apoptosis. The calculated fraction of ovary mitochondria in state 3 was at a minimal value at the P phase. Mitochondrial oxidative damage, with increased thiobarbituric acid-reactive substances and protein carbonyls, indicates progressive mitochondrial dysfunction between phases P and E. The roles of mitochondria as ATP provider, as a source of NO to signal for mitochondrial proliferation and mitochondria-dependent apoptosis, and as a source of O2 and H2O2 appear well adapted to serve the proliferation-apoptosis sequence of the ovarian cycle.
ovarian follicle; oxygen uptake; mitochondrial nitric oxide synthase; respiratory chain; oxidative damage
This article has been cited by other articles:
![]() |
E. P. Gomez-Sanchez, M. T. Gomez-Sanchez, A. F. de Rodriguez, D. G. Romero, M. P. Warden, M. W. Plonczynski, and C. E. Gomez-Sanchez Immunohistochemical Demonstration of the Mineralocorticoid Receptor, 11{beta}-Hydroxysteroid Dehydrogenase-1 and -2, and Hexose-6-phosphate Dehydrogenase in Rat Ovary J. Histochem. Cytochem., July 1, 2009; 57(7): 633 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zaobornyj, L. B. Valdez, D. E. Iglesias, M. Gasco, G. F. Gonzales, and A. Boveris Mitochondrial nitric oxide metabolism during rat heart adaptation to high altitude: effect of sildenafil, L-NAME, and L-arginine treatments Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1741 - H1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Carreras and J. J. Poderoso Mitochondrial nitric oxide in the signaling of cell integrated responses Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1569 - C1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Navarro and A. Boveris The mitochondrial energy transduction system and the aging process Am J Physiol Cell Physiol, February 1, 2007; 292(2): C670 - C686. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nisoli and M. O. Carruba Nitric oxide and mitochondrial biogenesis J. Cell Sci., July 15, 2006; 119(14): 2855 - 2862. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |